Vitamin K2 Market: Surge in Consumer Demand for Nutritional Supplements to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – The letter ‘K’ in the term vitamin K is derived from the Germanic word Koagulation.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The letter ‘K’ in the term vitamin K is derived from the Germanic word Koagulation. It means, the ability to prevent hemorrhage or to clot blood. Researches are being carried out on vitamin K2 and its role in osteoporosis, osteoarthritis, vascular calcification, cognition, and cancer. Lack of vitamin K2 has been directly correlated with osteoporosis and vascular calcification Vitamin K inhibits soft and vascular tissue petrification when activated.

Read Report Overview - https://www.transparencymarketresearch.com/vitamin-k2-market.html

Vitamin K2 MK-4 intake is quite safe. It does not induce hyper-coagulation. Vitamin K2 addition reduces inflammation in rheumatoid arthritis by lowering the CRP levels. Vitamin K2 could cause apoptosis in rheumatoid arthritis synovial cells. Vitamin K2 in the form of MK-7 is commonly used as a supplement. Usage of MK-7 beyond 50 ????gm/day is harmful for health, as it interferes in anticoagulation therapy.

Vitamin K2 inhibits the invasion and growth of hepatocellular carcinoma in the human body through protein kinase-A activation. It results in moderate suppression of tumor recurrence Menaquinones (vitamin K2) form a sub-family, wherein the length of the side chain ranges from 1 to 13 isoprene residues. The remaining isoprene is unsaturated.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66710

The menaquinones are denoted as MK-n. The “n” represents the number of isoprene residues placed in the aliphatic side chain. Moreover, menaquinones have a short chain such as in MK-4, whereas the long chain menaquinones are MK-7, MK-8, MK-9, and MK-10. All the menaquinones are present in the human diet. Some small proportion of MK-6 has also been found in other foods.

A traditional Japanese food named Natto, which is made of fermented soybeans, contains Bacillus subtilis. Natto is a high source of vitamin K2, primarily MK-7. It contains up to 1,100 mg of K2 per 100 grams of food. Vitamin K2 is produced by different types of bacteria such as lactic acid bacteria (which induce MK-8 and MK-9) and propionic acid bacteria (MK-10). Different targeting tissues have different transport systems for vitamins. No specific receptors for vitamin K have been identified over the outer membrane of many cells. It could be the LDL which binds the vitamin K and is carried inside. The vitamin K subsequently dissolves in the membrane structures of the cells.

Request for ToC - https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=66710

Vitamin K2 Market: Key Trends

The global vitamin K2 market is projected to be driven primarily by rise in vitamin deficiency disorders. Increase in health consciousness, surge in consumer demand for nutritional supplements, rise in esthetic standards, and increase in cases of osteoporosis are the other factors that propel the global market. Strict and unfavorable regulations by governments for the approval of supplements are factors expected to hamper market growth.

Vitamin K2 Market: Segmentation

The global vitamin K2 market can be segmented based on product type, source, form, application, and region. In terms of product type, the market can be categorized into MK-7, MK-4, and others. The MK-7 segment is projected to account for large market share due to increase in usage of dietary supplements. Based on source, the global vitamin K2 market can be bifurcated into natural and synthetic. The synthetic segment is anticipated to capture major market share because of high production.

In terms of form, the market can be classified into oil, powder, and others. The powder segment is expected to dominate the global market in terms of share, as powdered form of vitamins dissolve quickly in water and other liquids. Based on application, the global vitamin K2 market can be divided into Nutraceutical & food and pharmaceuticals. The Nutraceutical & food segment is likely to grow at a rapid pace due to high demand for nutritional and food supplements among customers to take care of different deficiencies.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=66710

Vitamin K2 Market: Regional Analysis

In terms of region, the global vitamin K2 market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is projected to be a major market for vitamin K2 during the forecast period.

Vitamin K2 Market: Competitive Landscape

Key players operating in the global vitamin K2 market are Kappa Bioscience, NattoPharma, GNOSIS S.p.A., Viridis BioPharma, Seebio Biotech, DSM, DuPont, Geneferm Biotechnology Co. Ltd., International Flavors & Fragrances, Inc., and KYOWA HAKKO BIO CO., LTD., among others.

More Trending Reports by Transparency Market Research –

Brazil Parenteral Nutrition Market: The Brazil parenteral nutrition market is expected to reach the value of US$ 311.08 Mn by the end of 2031.

Medical Enzyme Technology Market: The global medical enzyme technology market was valued at US$ 3.7 Bn in 2019. It is projected to expand at a considerable CAGR during the forecast period.

Equine Supplement Products Market: The global equine supplement products market is anticipated to reach US$ 111 Mn by the end of 2031.

Digestive Enzymes Market: The global market for digestive enzymes will likely expand at an impressive CAGR of 13.1% from 2017 to 2025 to become worth US$1,039.4 mn by 2025 from US$358.2 mn in 2016.

Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031.

Animal Health Care Market: The animal healthcare market in India is anticipated to exceed US$ 1.36 Bn by the end of 2031. The market in the country is projected to expand at a CAGR of 6.9% from 2022 to 2031.

Implantable Medical Devices Market: The U.S. implantable medical devices market is expected to reach the value of US$ 48.3 Bn by the end of 2028. It is estimated to expand at a CAGR of 9.5% from 2021 to 2028.

Albumin Market: The global albumin market is expected to reach the value of US$ 8.1 Bn by the end of 2031. It is estimated to expand at a CAGR of 6.1% from 2021 to 2031.

About Us

 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com